FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029199217> ?p ?o ?g. }

• W2029199217 endingPage "265" @default.
• W2029199217 startingPage "255" @default.
• W2029199217 abstract "Asymmetrical flow field-flow fractionation (AsFlFFF), a technique that provides direct measurement of particle size and diffusion coefficient, is converted into miniaturized scale. In comparison with conventional AsFlFFF, the separation of proteins in miniaturized AsFlFFF is achieved within shorter time periods, with smaller sample amounts, and with lower mobile phase consumption. Minimization of the overloading and optimization of the separation efficiency are prerequisites to good results. Miniaturized AsFlFFF is applied to the measurement of particle sizes of high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL). The average hydrodynamic diameters at pH 7.4 in 8.5mM phosphate buffer containing 1mM EDTA and 150 mM NaCl are 8.6+/-0.5, 11.2+/-0.2, 22.1+/-0.7, and 48.9+/-7.5 nm for subgroups HDL3, HDL2, LDL, and VLDL, respectively. In addition, the effect of different factors on the aggregation and fusion of LDL particles is studied. LDL particle sizes are unaffected by the addition of up to 300 mM NaCl and by an increase of the carrier solution pH from 3.2 to 7.4, but treatment of LDL with alpha-chymotrypsin, sphingomyelinase, or copper sulfate leads to the formation of aggregated and fused LDL particles." @default.
• W2029199217 created "2016-06-24" @default.
• W2029199217 creator A5032371830 @default.
• W2029199217 creator A5033690226 @default.
• W2029199217 creator A5043029186 @default.
• W2029199217 creator A5060492501 @default.
• W2029199217 creator A5061366766 @default.
• W2029199217 creator A5065844965 @default.
• W2029199217 creator A5074150839 @default.
• W2029199217 creator A5085875890 @default.
• W2029199217 date "2006-07-01" @default.
• W2029199217 modified "2023-10-18" @default.
• W2029199217 title "Miniaturization of asymmetrical flow field-flow fractionation and application to studies on lipoprotein aggregation and fusion" @default.
• W2029199217 cites W1486434785 @default.
• W2029199217 cites W1531773957 @default.
• W2029199217 cites W1775749144 @default.
• W2029199217 cites W1967800067 @default.
• W2029199217 cites W1971180330 @default.
• W2029199217 cites W1974222095 @default.
• W2029199217 cites W1976642167 @default.
• W2029199217 cites W1985574773 @default.
• W2029199217 cites W1993707348 @default.
• W2029199217 cites W2015481074 @default.
• W2029199217 cites W2016930143 @default.
• W2029199217 cites W2017244066 @default.
• W2029199217 cites W2017881977 @default.
• W2029199217 cites W2021587541 @default.
• W2029199217 cites W2023075356 @default.
• W2029199217 cites W2028495100 @default.
• W2029199217 cites W2032030730 @default.
• W2029199217 cites W2041157376 @default.
• W2029199217 cites W2042667997 @default.
• W2029199217 cites W2043598138 @default.
• W2029199217 cites W2043848847 @default.
• W2029199217 cites W2044458029 @default.
• W2029199217 cites W2054528642 @default.
• W2029199217 cites W2057355258 @default.
• W2029199217 cites W2062316680 @default.
• W2029199217 cites W2064965107 @default.
• W2029199217 cites W2074161440 @default.
• W2029199217 cites W2075103074 @default.
• W2029199217 cites W2076424306 @default.
• W2029199217 cites W2077097640 @default.
• W2029199217 cites W2079454363 @default.
• W2029199217 cites W2080866418 @default.
• W2029199217 cites W2084255011 @default.
• W2029199217 cites W2084268738 @default.
• W2029199217 cites W2094083742 @default.
• W2029199217 cites W2097640068 @default.
• W2029199217 cites W2103235919 @default.
• W2029199217 cites W2107818754 @default.
• W2029199217 cites W2134176648 @default.
• W2029199217 cites W2135336552 @default.
• W2029199217 cites W2135503869 @default.
• W2029199217 cites W2140269404 @default.
• W2029199217 cites W2161721693 @default.
• W2029199217 cites W2162462798 @default.
• W2029199217 cites W2187130512 @default.
• W2029199217 cites W2345534018 @default.
• W2029199217 cites W2417343387 @default.
• W2029199217 cites W2915324964 @default.
• W2029199217 cites W3915781 @default.
• W2029199217 doi "https://doi.org/10.1016/j.ab.2006.04.018" @default.
• W2029199217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16750506" @default.
• W2029199217 hasPublicationYear "2006" @default.
• W2029199217 type Work @default.
• W2029199217 sameAs 2029199217 @default.
• W2029199217 citedByCount "47" @default.
• W2029199217 countsByYear W20291992172012 @default.
• W2029199217 countsByYear W20291992172014 @default.
• W2029199217 countsByYear W20291992172015 @default.
• W2029199217 countsByYear W20291992172017 @default.
• W2029199217 countsByYear W20291992172019 @default.
• W2029199217 countsByYear W20291992172020 @default.
• W2029199217 countsByYear W20291992172021 @default.
• W2029199217 countsByYear W20291992172022 @default.
• W2029199217 crossrefType "journal-article" @default.
• W2029199217 hasAuthorship W2029199217A5032371830 @default.
• W2029199217 hasAuthorship W2029199217A5033690226 @default.
• W2029199217 hasAuthorship W2029199217A5043029186 @default.
• W2029199217 hasAuthorship W2029199217A5060492501 @default.
• W2029199217 hasAuthorship W2029199217A5061366766 @default.
• W2029199217 hasAuthorship W2029199217A5065844965 @default.
• W2029199217 hasAuthorship W2029199217A5074150839 @default.
• W2029199217 hasAuthorship W2029199217A5085875890 @default.
• W2029199217 hasConcept C113196181 @default.
• W2029199217 hasConcept C138885662 @default.
• W2029199217 hasConcept C147789679 @default.
• W2029199217 hasConcept C158525013 @default.
• W2029199217 hasConcept C185592680 @default.
• W2029199217 hasConcept C187530423 @default.
• W2029199217 hasConcept C192562407 @default.
• W2029199217 hasConcept C2778163477 @default.
• W2029199217 hasConcept C2779620165 @default.
• W2029199217 hasConcept C2780072125 @default.
• W2029199217 hasConcept C41895202 @default.
• W2029199217 hasConcept C43617362 @default.
• W2029199217 hasConcept C55493867 @default.

• next